175 related articles for article (PubMed ID: 21958554)
1. Receptor fusion proteins for the inhibition of cytokines.
Schwache D; Müller-Newen G
Eur J Cell Biol; 2012; 91(6-7):428-34. PubMed ID: 21958554
[TBL] [Abstract][Full Text] [Related]
2. Activation of target signal transducers utilizing chimeric receptors with signaling-molecule binding motifs.
Saka K; Kawahara M; Ueda H; Nagamune T
Biotechnol Bioeng; 2012 Jun; 109(6):1528-37. PubMed ID: 22228507
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of cytokine receptor activation.
Lopez AF; Hercus TR; Ekert P; Littler DR; Guthridge M; Thomas D; Ramshaw HS; Stomski F; Perugini M; D'Andrea R; Grimbaldeston M; Parker MW
IUBMB Life; 2010 Jul; 62(7):509-18. PubMed ID: 20540154
[TBL] [Abstract][Full Text] [Related]
4. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways.
Haarmann-Stemmann T; Bothe H; Abel J
Biochem Pharmacol; 2009 Feb; 77(4):508-20. PubMed ID: 18848820
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.
Karikó K; Weissman D; Welsh FA
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1288-304. PubMed ID: 15545925
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the immune system by SOCS family adaptor proteins.
Ilangumaran S; Ramanathan S; Rottapel R
Semin Immunol; 2004 Dec; 16(6):351-65. PubMed ID: 15541651
[TBL] [Abstract][Full Text] [Related]
7. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic diversity of cytokine receptor signaling across cell membranes.
Stroud RM; Wells JA
Sci STKE; 2004 Apr; 2004(231):re7. PubMed ID: 15126678
[TBL] [Abstract][Full Text] [Related]
9. Shared cytokine signaling receptors: structural insights from the gp130 system.
Boulanger MJ; Garcia KC
Adv Protein Chem; 2004; 68():107-46. PubMed ID: 15500860
[TBL] [Abstract][Full Text] [Related]
10. From cellular receptors to transduction-transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation?
Dayer JM; Molnarfi N; Burger D
Expert Opin Biol Ther; 2005 Sep; 5 Suppl 1():S83-96. PubMed ID: 16187943
[TBL] [Abstract][Full Text] [Related]
11. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
Heim MH
J Recept Signal Transduct Res; 1999; 19(1-4):75-120. PubMed ID: 10071751
[TBL] [Abstract][Full Text] [Related]
12. Regulation of STAT-dependent pathways by growth factors and cytokines.
Leaman DW; Leung S; Li X; Stark GR
FASEB J; 1996 Dec; 10(14):1578-88. PubMed ID: 9002549
[TBL] [Abstract][Full Text] [Related]
13. Cytokine receptor activation at the cell surface.
Broughton SE; Hercus TR; Lopez AF; Parker MW
Curr Opin Struct Biol; 2012 Jun; 22(3):350-9. PubMed ID: 22521507
[TBL] [Abstract][Full Text] [Related]
14. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?
Andreakos E; Foxwell B; Feldmann M
Immunol Rev; 2004 Dec; 202():250-65. PubMed ID: 15546398
[TBL] [Abstract][Full Text] [Related]
15. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC
Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301
[TBL] [Abstract][Full Text] [Related]
16. Plasticity and cross-talk of interleukin 6-type cytokines.
Garbers C; Hermanns HM; Schaper F; Müller-Newen G; Grötzinger J; Rose-John S; Scheller J
Cytokine Growth Factor Rev; 2012 Jun; 23(3):85-97. PubMed ID: 22595692
[TBL] [Abstract][Full Text] [Related]
17. Specificity of signaling by hematopoietic cytokine receptors: instructive versus permissive effects.
Skoda RC
J Recept Signal Transduct Res; 1999; 19(1-4):741-72. PubMed ID: 10071797
[TBL] [Abstract][Full Text] [Related]
18. Jaks and cytokine receptors--an intimate relationship.
Haan C; Kreis S; Margue C; Behrmann I
Biochem Pharmacol; 2006 Nov; 72(11):1538-46. PubMed ID: 16750817
[TBL] [Abstract][Full Text] [Related]
19. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the leukemia inhibitory factor receptor functional domains by chimeric receptors and cytokines.
Aasland D; Schuster B; Grötzinger J; Rose-John S; Kallen KJ
Biochemistry; 2003 May; 42(18):5244-52. PubMed ID: 12731865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
